The following data is part of a premarket notification filed by Traxtal Technologies Inc. with the FDA for Abaris.
Device ID | K053610 |
510k Number | K053610 |
Device Name: | ABARIS |
Classification | System, X-ray, Tomography, Computed |
Applicant | TRAXTAL TECHNOLOGIES INC. 49 SPADINA AVENUE, #402C Toronto, Ontario, CA M5v 2j1 |
Contact | Neil Glossop |
Correspondent | Neil Glossop TRAXTAL TECHNOLOGIES INC. 49 SPADINA AVENUE, #402C Toronto, Ontario, CA M5v 2j1 |
Product Code | JAK |
CFR Regulation Number | 892.1750 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2005-12-27 |
Decision Date | 2006-04-19 |
Summary: | summary |
Device Identifier | submissionNumber | Supplement |
---|---|---|
00884838083592 | K053610 | 000 |
00884838081550 | K053610 | 000 |
00884838081543 | K053610 | 000 |
00884838066991 | K053610 | 000 |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ABARIS 86964155 5510696 Live/Registered |
Profound Nutrition Limited 2016-04-05 |
ABARIS 73780780 1563875 Dead/Cancelled |
ABARIS 1989-02-10 |